{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:03:52Z","timestamp":1790964232071,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"French government under the France 2030 investment plan, as part of the Initiative d'Excellence d'Aix-Marseille Universit\u00e9 - A*MIDEX - Institute of Public Health Sciences of Aix-Marseille","award":["AMX-20-IET-014"],"award-info":[{"award-number":["AMX-20-IET-014"]}]},{"name":"Excellence Initiative of Aix-Marseille University - A*MIDEX, a French \u201cInvestissements d\u2019Avenir\u201d programme","award":["A*Midex International 2018"],"award-info":[{"award-number":["A*Midex International 2018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-024-05078-8","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T12:03:06Z","timestamp":1726488186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prospective acceptability of mass drug administration for malaria in Kedougou region in Senegal: a mixed method study"],"prefix":"10.1186","volume":"23","author":[{"given":"Eva","family":"Legendre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Ndiaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nd\u00e8ye Mareme","family":"Sougou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Gaudart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El Hadj","family":"Ba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ry","family":"Ridde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Landier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"5078_CR1","volume-title":"World malaria report 2023","author":"WHO","year":"2023","unstructured":"WHO. World malaria report 2023. Geneva: World Health Organization; 2023."},{"key":"5078_CR2","unstructured":"National Malaria Control Programme \u2013 Senegal. Annual epidemiological bulletin 2021 on malaria in Senegal. Available from: Unpublished data"},{"key":"5078_CR3","unstructured":"National Malaria Control Programme, Ministry of Health and Social Action. National Strategic Plan for Malaria Control in Senegal 2021\u20132025. Dakar, 2020. https:\/\/senegal-cocreation.com\/wp-content\/uploads\/2021\/02\/PSN_PNLP_Senegal_Version-finale_-Fevrier-2021.pdf. Accessed 2 Sep 2024."},{"key":"5078_CR4","unstructured":"National Malaria Control Programme \u2013 Senegal. Annual epidemiological bulletin 2019 on malaria in Senegal. 2020. https:\/\/pnlp.sn\/bulletin-epidemiologique-annuel\/. Accessed 2 Sep 2024."},{"key":"5078_CR5","unstructured":"National Agency of Statistics and Demography. Senegal: Continuous Demographic and Health Survey (DHS) 2017. Dakar, 2018. https:\/\/dhsprogram.com\/publications\/publication-fr345-dhs-final-reports.cfm.Accessed 2 Sep 2024."},{"key":"5078_CR6","unstructured":"National Agency of Statistics and Demography. Malaria indicator survey (MIS) in Senegal 2020\u20132021. Dakar, 2022. https:\/\/dhsprogram.com\/publications\/publication-MIS38-MIS-Final-Reports.cfm. Accessed 2 Sep 2024."},{"key":"5078_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12936-023-04519-0","volume":"22","author":"A Ahmad","year":"2023","unstructured":"Ahmad A, Mohammed NI, Joof F, Affara M, Jawara M, Abubakar I, et al. Asymptomatic Plasmodium falciparum carriage and clinical disease: a 5-year community-based longitudinal study in the Gambia. Malar J. 2023;22:82.","journal-title":"Malar J"},{"key":"5078_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12936-017-1749-4","volume":"16","author":"FG Tadesse","year":"2017","unstructured":"Tadesse FG, van den Hoogen L, Lanke K, Schildkraut J, Tetteh K, Aseffa A, et al. The shape of the iceberg: quantification of submicroscopic Plasmodium falciparum and Plasmodium vivax parasitaemia and gametocytaemia in five low endemic settings in Ethiopia. Malar J. 2017;16:99.","journal-title":"Malar J"},{"key":"5078_CR9","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.4269\/ajtmh.17-0074","volume":"97","author":"D Coulibaly","year":"2017","unstructured":"Coulibaly D, Travassos MA, Tolo Y, Laurens MB, Kone AK, Traore K, et al. Spatio-temporal dynamics of asymptomatic malaria: bridging the gap between annual malaria resurgences in a Sahelian Environment. Am J Trop Med Hyg. 2017;97:1761\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"5078_CR10","doi-asserted-by":"publisher","first-page":"582","DOI":"10.4269\/ajtmh.1998.59.582","volume":"59","author":"HA Babiker","year":"1998","unstructured":"Babiker HA, Abdel-Muhsin AM, Ranford-Cartwright LC, Satti G, Walliker D. Characteristics of Plasmodium falciparum parasites that survive the lengthy dry season in eastern Sudan where malaria transmission is markedly seasonal. Am J Trop Med Hyg. 1998;59:582\u201390.","journal-title":"Am J Trop Med Hyg"},{"key":"5078_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0035-9203(99)90122-0","volume":"93","author":"J Zwetyenga","year":"1999","unstructured":"Zwetyenga J, Rogier C, Spiegel A, Fontenille D, Trape JF, Mercereau-Puijalon O. A cohort study of Plasmodium falciparum diversity during the dry season in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. Trans R Soc Trop Med Hyg. 1999;93:375\u201380.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5078_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.pt.2015.11.015","volume":"32","author":"B Galatas","year":"2016","unstructured":"Galatas B, Bassat Q, Mayor A. Malaria parasites in the asymptomatic: looking for the hay in the haystack. Trends Parasitol. 2016;32:296\u2013308.","journal-title":"Trends Parasitol"},{"key":"5078_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12936-022-04133-6","volume":"21","author":"EMA Beni\u00e9","year":"2022","unstructured":"Beni\u00e9 EMA, Silu\u00e9 KD, Ding XC, Yeo I, Assamoi JB, Tuo K, et al. Accuracy of a rapid diagnosis test, microscopy and loop-mediated isothermal amplification in the detection of asymptomatic infections in Korhogo. Northern C\u00f4te d\u2019Ivoire Malar J. 2022;21:111.","journal-title":"Northern C\u00f4te d\u2019Ivoire Malar J"},{"key":"5078_CR14","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1128\/JCM.03615-13","volume":"52","author":"B Wang","year":"2014","unstructured":"Wang B, Han SS, Cho C, Han JH, Cheng Y, Lee SK, et al. Comparison of microscopy, nested-PCR, and Real-Time-PCR assays using high-throughput screening of pooled samples for diagnosis of malaria in asymptomatic carriers from areas of endemicity in Myanmar. J Clin Microbiol. 2014;52:1838\u201345.","journal-title":"J Clin Microbiol"},{"key":"5078_CR15","volume-title":"Global malaria programme a framework for malaria elimination","author":"WHO","year":"2017","unstructured":"WHO. Global malaria programme a framework for malaria elimination. Geneva: World Health Organization; 2017."},{"key":"5078_CR16","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/S0140-6736(18)30792-X","volume":"391","author":"J Landier","year":"2018","unstructured":"Landier J, Parker DM, Thu AM, Lwin KM, Delmas G, Nosten FH, et al. Effect of generalised access to early diagnosis and treatment and targeted mass drug administration on Plasmodium falciparum malaria in Eastern Myanmar: an observational study of a regional elimination programme. Lancet. 2018;391:1916\u201326.","journal-title":"Lancet"},{"key":"5078_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1473-3099(21)00557-0","volume":"22","author":"ED Dabira","year":"2022","unstructured":"Dabira ED, Soumare HM, Conteh B, Ceesay F, Ndiath MO, Bradley J, et al. Mass drug administration of ivermectin and dihydroartemisinin\u2013piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia. Lancet Infect Dis. 2022;22:519\u201328.","journal-title":"Lancet Infect Dis"},{"key":"5078_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002745","volume":"16","author":"L von Seidlein","year":"2019","unstructured":"von Seidlein L, Peto TJ, Landier J, Nguyen TN, Tripura R, Phommasone K, et al. The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: a cluster randomised trial. PLoS Med. 2019;16: e1002745.","journal-title":"PLoS Med"},{"key":"5078_CR19","unstructured":"ClinicalTrials.gov. Study Details - Mass drug administration of dihydroartemisinin-piperaquine + single low-dose primaquine to accelerate toward elimination activitiesClinicalTrials.gov. Accessed on September 2, 2024. https:\/\/clinicaltrials.gov\/study\/NCT04864444"},{"key":"5078_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","volume":"17","author":"M Sekhon","year":"2017","unstructured":"Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17:88.","journal-title":"BMC Health Serv Res"},{"key":"5078_CR21","volume-title":"Adherence to long-term therapies: evidence for action","author":"WHO","year":"2003","unstructured":"WHO. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003."},{"key":"5078_CR22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1186\/s13071-021-05064-y","volume":"14","author":"PL Aung","year":"2021","unstructured":"Aung PL, Soe MT, Soe TN, Oo TL, Aung PP, Khin A, et al. The acceptability of targeted mass treatment with primaquine for local elimination of vivax malaria in a northern Myanmar township: a mixed-methods study. Parasit Vectors. 2021;14:549.","journal-title":"Parasit Vectors"},{"key":"5078_CR23","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12936-021-03732-z","volume":"20","author":"A Fehr","year":"2021","unstructured":"Fehr A, Nieto-Sanchez C, Muela J, Jaiteh F, Ceesay O, Maneh E, et al. From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in the Gambia. Malar J. 2021;20:198.","journal-title":"Malar J"},{"key":"5078_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12936-021-03679-1","volume":"20","author":"KW Roberts","year":"2021","unstructured":"Roberts KW, Smith Gueye C, Baltzell K, Ntuku H, McCreesh P, Maglior A, et al. Community acceptance of reactive focal mass drug administration and reactive focal vector control using indoor residual spraying, a mixed-methods study in Zambezi region. Namibia Malar J. 2021;20:162.","journal-title":"Namibia Malar J"},{"key":"5078_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249080","volume":"16","author":"B Galatas","year":"2021","unstructured":"Galatas B, Nhantumbo H, Soares R, Djive H, Murato I, Simone W, et al. Community acceptability to antimalarial mass drug administrations in Magude district, Southern Mozambique: a mixed methods study. PLoS ONE. 2021;16: e0249080.","journal-title":"PLoS ONE"},{"key":"5078_CR26","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41467-019-08297-9","volume":"10","author":"P Chotsiri","year":"2019","unstructured":"Chotsiri P, Zongo I, Milligan P, Compaore YD, Som\u00e9 AF, Chandramohan D, et al. Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children. Nat Commun. 2019;10:480.","journal-title":"Nat Commun"},{"key":"5078_CR27","unstructured":"Mixed Methods Appraisal Tool (MMAT) Version 2018 User Guide | NCCMT. https:\/\/www.nccmt.ca\/knowledge-repositories\/search\/232%20(accessed%20May%202017. Accessed  2 Sep 2024."},{"key":"5078_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","volume":"42","author":"LA Palinkas","year":"2015","unstructured":"Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42:533\u201344.","journal-title":"Adm Policy Ment Health"},{"key":"5078_CR29","unstructured":"Louart S, Hedible GB, Ridde V. What is acceptability of health innovations? Example of pulse oximeter integrated into PCIME management in primary health centers in West Africa. Dakar, Senegal; 2015."},{"key":"5078_CR30","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","volume":"8","author":"D Wild","year":"2005","unstructured":"Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8:94\u2013104.","journal-title":"Value Health"},{"key":"5078_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/ije\/dyu086","volume":"43","author":"G Pison","year":"2014","unstructured":"Pison G, Douillot L, Kante AM, Ndiaye O, Diouf PN, Senghor P, et al. Health & demographic surveillance system profile: bandafassi health and demographic surveillance system (Bandafassi HDSS). Senegal Int J Epidemiol. 2014;43:739\u201348.","journal-title":"Senegal Int J Epidemiol"},{"key":"5078_CR32","volume-title":"Qualitative data analysis for applied policy research analyzing qualitative data","author":"J Ritchie","year":"1994","unstructured":"Ritchie J, Spencer L. Qualitative data analysis for applied policy research analyzing qualitative data. Oxfordshire: Routledge; 1994."},{"key":"5078_CR33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.worlddev.2015.03.013","volume":"72","author":"M Garenne","year":"2015","unstructured":"Garenne M. Traditional Wealth, modern Goods, and demographic Behavior in Rural Senegal. World Dev. 2015;72:267\u201376.","journal-title":"World Dev"},{"key":"5078_CR34","unstructured":"Coste M. The poor and the healthy: unpacking health capability in rural Senegal. Working paper. 2023;"},{"key":"5078_CR35","unstructured":"R: The R Project for Statistical Computing. https:\/\/www.r-project.org\/. Accessed 18 Aug 2023."},{"key":"5078_CR36","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/fampra\/cmz010","volume":"36","author":"N Kaur","year":"2019","unstructured":"Kaur N, Vedel I, El Sherif R, Pluye P. Practical mixed methods strategies used to integrate qualitative and quantitative methods in community-based primary health care research. Fam Pract. 2019;36:666\u201371.","journal-title":"Fam Pract"},{"key":"5078_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1177\/1049732305285708","volume":"16","author":"T Farmer","year":"2006","unstructured":"Farmer T, Robinson K, Elliott SJ, Eyles J. Developing and implementing a triangulation protocol for qualitative health research. Qual Health Res. 2006;16:377\u201394.","journal-title":"Qual Health Res"},{"issue":"2","key":"5078_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4269\/ajtmh.19-0663","volume":"103","author":"K Silumbe","year":"2020","unstructured":"Silumbe K, Finn TP, Jennings T, Sikombe C, Chiyende E, Hamainza B, et al. Assessment of the acceptability of testing and treatment during a mass drug administration trial for malaria in Zambia using mixed methods. Am J Trop Med Hyg. 2020;103(2):28\u201336.","journal-title":"Am J Trop Med Hyg"},{"key":"5078_CR39","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/trstmh\/try053","volume":"112","author":"TJ Peto","year":"2018","unstructured":"Peto TJ, Tripura R, Sanann N, Adhikari B, Callery J, Droogleever M, et al. The feasibility and acceptability of mass drug administration for malaria in Cambodia: a mixed-methods study. Trans R Soc Trop Med Hyg. 2018;112:264\u201371.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5078_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1475-2875-13-47","volume":"13","author":"NJ Dial","year":"2014","unstructured":"Dial NJ, Ceesay SJ, Gosling RD, D\u2019Alessandro U, Baltzell KA. A qualitative study to assess community barriers to malaria mass drug administration trials in the Gambia. Malar J. 2014;13:47.","journal-title":"Malar J"},{"issue":"1","key":"5078_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12936-016-1662-2","volume":"16","author":"TN Nguyen","year":"2017","unstructured":"Nguyen TN, Thu PNH, Hung NT, Son DH, Tien NT, Van Dung N, et al. Community perceptions of targeted anti-malarial mass drug administrations in two provinces in Vietnam: a quantitative survey. Malar J. 2017;16(1):17.","journal-title":"Malar J"},{"key":"5078_CR42","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s12936-018-2624-7","volume":"17","author":"H Wanzira","year":"2018","unstructured":"Wanzira H, Naiga S, Mulebeke R, Bukenya F, Nabukenya M, Omoding O, et al. Community facilitators and barriers to a successful implementation of mass drug administration and indoor residual spraying for malaria prevention in Uganda: a qualitative study. Malar J. 2018;17:474.","journal-title":"Malar J"},{"key":"5078_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12936-017-2158-4","volume":"17","author":"B Adhikari","year":"2018","unstructured":"Adhikari B, Phommasone K, Kommarasy P, Soundala X, Souvanthong P, Pongvongsa T, et al. Why do people participate in mass anti-malarial administration? findings from a qualitative study in Nong District, Savannakhet Province, Lao PDR (Laos). Malar J. 2018;17:15.","journal-title":"Malar J"},{"key":"5078_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011146","volume":"17","author":"BB Fuller","year":"2023","unstructured":"Fuller BB, Harris V, Parker C, Martinez A, Toubali E, Ebene BC, et al. Contextual determinants of mass drug administration performance: modelling fourteen years of lymphatic filariasis treatments in West Africa. PLoS Negl Trop Dis. 2023;17: e0011146.","journal-title":"PLoS Negl Trop Dis"},{"key":"5078_CR45","volume-title":"Seasonal dynamics of Plasmodium falciparum asymptomatic reservoir in Sahelian Africa","author":"J Landier","year":"2022","unstructured":"Landier J. Seasonal dynamics of Plasmodium falciparum asymptomatic reservoir in Sahelian Africa. Bangkok, Thailand: The Royal Society London; 2022."},{"key":"5078_CR46","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1046\/j.1365-3156.2001.00723.x","volume":"6","author":"S De Martin","year":"2001","unstructured":"De Martin S, von Seidlein L, Deen JL, Pinder M, Walraven G, Greenwood B. Community perceptions of a mass administration of an antimalarial drug combination in The Gambia. Trop Med Int Health. 2001;6:442\u20138.","journal-title":"Trop Med Int Health"},{"key":"5078_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148627","volume":"11","author":"S Dierickx","year":"2016","unstructured":"Dierickx S, Gryseels C, Mwesigwa J, O\u2019Neill S, Bannister-Tyrell M, Ronse M, et al. Factors associated with non-participation and non-adherence in directly observed mass drug administration for malaria in The Gambia. PLoS ONE. 2016;11: e0148627.","journal-title":"PLoS ONE"},{"key":"5078_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2202-z","author":"TJ Peto","year":"2018","unstructured":"Peto TJ, Debackere M, Etienne W, Vernaeve L, Tripura R, Falq G, et al. Community participation during two mass anti-malarial administrations in Cambodia: lessons from a joint workshop. Malar J. 2018. https:\/\/doi.org\/10.1186\/s12936-018-2202-z.","journal-title":"Malar J"},{"key":"5078_CR49","doi-asserted-by":"publisher","first-page":"116","DOI":"10.12688\/wellcomeopenres.14698.1","volume":"3","author":"D Tangseefa","year":"2018","unstructured":"Tangseefa D, Monthathip K, Tuenpakdee N, K\u00f6nig A, Kajeechiwa L, Thwin MM, et al. \u2018Nine Dimensions\u2019: a multidisciplinary approach for community engagement in a complex postwar border region as part of the targeted malaria examination in Karen\/Kayin State. Myanmar Wellcome Open Res. 2018;3:116.","journal-title":"Myanmar Wellcome Open Res"},{"key":"5078_CR50","unstructured":"Clinical and Translational Science Awards Consortium, Community Engagement Key Function Committee Task, Force on the Principles of Community Engagement. Principles of Community Engagement. 2nd Edn. 2011. (NIH Publication). https:\/\/www.atsdr.cdc.gov\/communityengagement\/index.html. Accessed 2 Sep 2024."},{"key":"5078_CR51","unstructured":"G\u00e9o S\u00e9n\u00e9gal. Digital Elevation Model 30 m. https:\/\/www.geosenegal.gouv.sn\/-Modeles-numeriques-de-terrain-30-m-.html. Accessed 2 Sep 2024."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-024-05078-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-024-05078-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-024-05078-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T12:04:45Z","timestamp":1726488285000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-024-05078-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5078"],"URL":"https:\/\/doi.org\/10.1186\/s12936-024-05078-8","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"6 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"279"}}